PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 197 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $768,000 | +9.4% | 12,772 | -4.5% | 0.01% | -6.7% |
| Q2 2020 | $702,000 | +52.3% | 13,371 | -2.8% | 0.02% | +25.0% |
| Q1 2020 | $461,000 | -29.9% | 13,755 | -5.3% | 0.01% | -20.0% |
| Q4 2019 | $658,000 | +139.3% | 14,521 | +100.8% | 0.02% | +114.3% |
| Q3 2019 | $275,000 | -10.7% | 7,230 | +2.2% | 0.01% | -12.5% |
| Q2 2019 | $308,000 | +5.8% | 7,075 | -7.5% | 0.01% | 0.0% |
| Q1 2019 | $291,000 | -27.2% | 7,647 | -28.3% | 0.01% | -42.9% |
| Q3 2017 | $400,000 | -14.5% | 10,664 | +8.6% | 0.01% | -22.2% |
| Q2 2017 | $468,000 | -18.6% | 9,818 | -22.2% | 0.02% | -25.0% |
| Q1 2017 | $575,000 | – | 12,620 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |